{
    "2019-06-30": [
        [
            {
                "time": "",
                "original_text": "博济医药年报大秀财技，交易所的问询被“神回复” 问询",
                "features": {
                    "keywords": [
                        "博济医药",
                        "年报",
                        "财技",
                        "问询",
                        "神回复"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：全资子公司拟720万美元收购美国BDM公司45%股权",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "全资子公司",
                        "收购",
                        "美国BDM",
                        "股权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)子公司拟720万美元购买孙公司美国BDM45%股权",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "子公司",
                        "购买",
                        "美国BDM",
                        "股权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "获高盛看好，方达控股涨逾15%",
                "features": {
                    "keywords": [
                        "高盛",
                        "看好",
                        "方达控股",
                        "涨逾15%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}